Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy -- Ignore unavailable to you. Want to Upgrade?

To: Todd A. Sinelli who wrote (108)	4/6/1998 10:11:00 AM
From: deadstrait	Read Replies (1) \| Respond to of 184

Todd, I have been out of town quite a bit recently, but I do have the following to share with you. There are more than three MMs working this stock. They are Robertson Stephens, H & Q, Merrill Lynch, Nationsbanc Montgomery Secs., Raymond James, Knight Securities, Mayer & Schweitzer, and there are several more. Robertson Stephens is the most active with about 45% of the total shares traded. I do not see Schwab listed. Anyway, the F in FDA does not stand for fast. Thymo approval should be this 1/4 with SANG35 around mid year. later dead